ACTU Earnings Preview
Actuate Therapeutics, Inc. Common stock · Healthcare · $70M
ACTU Earnings
Friday, May 15 2026
EPS Estimate
$-0.21
$-0.24 – $-0.18
Current Price
$2.88
Data Signal Summary
1 bullish
2 bearish
Estimates up +17%
Insider selling cluster
Price downtrend
Key Context
Analyst Consensus
mixed
Insider Activity
selling
Price Trend
downtrend
From 52w High
-3.0%
Est. Revisions (30d)
+17.0% 2up/0dn
Analyst Target (mean)
$14 $6–$25 +369%
Est. Dispersion
29% 4 analysts
Insider Cluster
sell cluster
Recent Activity
insider trades
8 transactions
Exercise
·
BIOS EQUITY COF, LP (Beneficial Owner of more than 10% of a Class of Security)
·9,418,650 shares
·$200,002
Other
·
SCHMITT DANIEL M. (Chief Executive Officer)
·272,055 shares
Sell
·
THOMSON TODD S. (Director and Beneficial Owner of more than 10% of a Class of Security)
·280,000 shares
·$1,624,000
Buy
·
BIOS EQUITY COF, LP (Beneficial Owner of more than 10% of a Class of Security)
·71,428 shares
·$499,996
Sell
·
THOMSON TODD S. (Director and Beneficial Owner of more than 10% of a Class of Security)
·18,750 shares
·$150,000
3 more
Other
·
THOMSON TODD S.
·2,605,776 shr
Buy
·
BIOS EQUITY COF, LP
·500,000 shr
·$4,000,000
Sell
·
BIOS EQUITY COF, LP
·24,999 shr
·$199,992
analyst ratings
1 rating
HC Wainwright & Co.
→Buy
8d ago
Explore more
